AUS
NZ
UK
CA
USA
IND
The Australian share market has seen significant movements with Hub24 Ltd and ResMed CDI making headlines. As a standout ASX growth stock, Hub24 Ltd has experienced a remarkable 55.9% increase in its share price since the start of 2024, reflecting its strong performance and growing influence in the wealth management sector. Meanwhile, ResMed CDI has seen its shares rebound approximately 78.9% from their 52-week low, showcasing the company's recovery and ongoing strength in the medical equipment industry. This article provides a detailed look at the recent developments for both companies and their market impact.
Hub24 Ltd (ASX:HUB) Shares Surge 55.9% in 2024
Hub24 Ltd has seen an impressive 55.9% increase in its share price since the beginning of 2024. Founded in 2007, Hub24 has quickly established itself as a major player in the wealth management sector. The company offers a suite of platforms designed to streamline financial advice, superannuation, and investment management.
Hub24's key products include:
- HUB24: A platform for financial advisers and their clients, providing access to a diverse range of managed funds and investment products.
- Class: Software designed for managing self-managed super funds, including portfolio management, legal documentation, and compliance.
- myprosperity: A client portal solution for accountants and advisers, enhancing service delivery and client experience.
In 2024, Hub24 has been recognized for its exceptional service. The company was awarded Overall Best Platform in the Adviser Ratings Financial Advice Landscape Report and ranked first for Overall Satisfaction and Brand Image and Reputation in the 2024 Wealth Insights Platform Service Level Report.
HUB shares currently have a price-to-sales ratio of 13.85x, compared to a 5-year average of 11.61x. This indicates that the shares are trading above their historical average, reflecting the company's strong performance and growth prospects.
ResMed CDI (ASX:RMD) Shares Climb from 52-Week Low
ResMed CDI shares have rebounded significantly, climbing approximately 78.9% from their 52-week low. Founded in 1989 by Peter Farrell in Australia, ResMed is a leading medical equipment company headquartered in San Diego, California. The company specializes in cloud-connected continuous positive airway pressure (CPAP) machines used for treating obstructive sleep apnea (OSA).
ResMed operates on a global scale with over 10,000 employees and a presence in more than 140 countries. The company is divided into two main business units:
- Sleep and Respiratory Care: This unit provides industry-leading CPAP machines for sleep apnea and other respiratory care solutions.
- Software as a Service (SaaS): This division offers software solutions for durable medical equipment (DME) and home medical equipment (HME), aimed at improving out-of-hospital care.
Leveraging its extensive digital health network, ResMed integrates its advanced hardware with SaaS data to drive insights, enhance patient outcomes, and reduce overall healthcare costs.
Both Hub24 Ltd and ResMed CDI have demonstrated notable performance in recent months. Hub24's substantial share price increase reflects its strong market position and service excellence, while ResMed's recovery from a 52-week low highlights its resilience and growth potential in the healthcare sector.
